• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.090 -0.070 (-1.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
May 13, 2025
 
Via Benzinga
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
May 13, 2025
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
May 13, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
April 01, 2025
Via ACCESS Newswire
News headline image
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
May 13, 2025
Via ACCESS Newswire
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications
May 13, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
May 13, 2025
Via Benzinga
News headline image
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
May 13, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
May 09, 2025
 
Via Benzinga
Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells
May 09, 2025
Via Investor Brand Network
AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds
April 30, 2025
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
April 24, 2025
 
Via Benzinga
Study Identifies Key Enzyme That Could Be Targeted to Fight Brain Cancers
April 23, 2025
Via Investor Brand Network
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
April 17, 2025
Via Investor Brand Network
News headline image
Top stock movements in today's session. ↗
April 15, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
The market is filled with gapping stocks in Tuesday's session. ↗
April 15, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
News headline image
Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches
April 07, 2025
Via Investor Brand Network
News headline image
Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers
April 02, 2025
Via Investor Brand Network
News headline image
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position
April 01, 2025
Via Investor Brand Network
Firefighters Have an Increased Chance of Having Gene Mutations Associated with Brain Cancer, Study Says
March 27, 2025
Via Investor Brand Network
News headline image
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session. ↗
March 25, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
March 25, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
March 25, 2025
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 25, 2025
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Nasdaq Gains 50 Points; US New Home Sales Rise In February ↗
March 25, 2025
 
Via Benzinga
News headline image
CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects ↗
March 25, 2025
CNS Pharmaceuticals' Berubicin trial results show a favorable safety profile with no cardiotoxicity and comparable efficacy to Lomustine in recurrent GBM. 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Phase 2 Results for Berubicin in Glioblastoma Trial
March 25, 2025
Via Investor Brand Network
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
March 25, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
US Stocks Mixed; Core & Main Posts Downbeat Earnings ↗
March 25, 2025
 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
March 25, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap